UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
The Center for Medicinal Cannabis Research at University of California San Diego School of Medicine announces $3 million in research grants to explore new applications of cannabis for a number of novel medical applications.
Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego researchers describe new use of leukemia drug, nilotinib, to treat subtype of medulloblastoma, a deadly pediatric brain cancer.
As the opioid tramadol has grown in popularity so too have documented cases of adverse effects. In a new study, researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego show that patients who take tramadol are at greater risk for hypoglycemia, abnormally low blood sugar.
The T. Denny Sanford Institute for Empathy and Compassion at UC San Diego will investigate the neurological basis of compassion, design a compassion-focused medical curriculum and develop new methods to protect and promote the well-being of current clinicians and their patients.
The San Diego Supercomputer Center (SDSC) at UC San Diego has been awarded a five-year grant from the National Science Foundation (NSF) worth $10 million to deploy Expanse, a new supercomputer designed to advance research that is increasingly dependent upon heterogeneous and distributed resources.
UC San Diego chemists offer new system to ease the synthesis and evaluation of the algorithms, the chemistry and the technology needed to predict the bound poses of ligands within a targeted protein—a necessity for designing new drugs.
Forbes, May 29
San Diego Union Tribune, May 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
